MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review

March 2021 | 58 pages | ID: M9A7E6ED26AEN
GlobalData

Abstracts

MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MacroGenics Inc (MacroGenics) is a biopharmaceutical company which focuses on the development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its pipeline includes product candidates for the treatment of solid tumors, breast and gastroesophageal cancers, type 1 diabetes, HIV, DART product candidates for the treatment of acute myeloid leukemia and myelodysplastic syndrome; and b-cell malignancies. The company’s product candidates are based on proprietary technology platforms, namely, Cancer Stem Cell Platform, Dual-Affinity Re-Targeting (or DART) and TRIDENT Platform and Fc Optimization Platform. It works in collaboration with major pharmaceutical and biotechnology companies to leverage its technology platforms and protein engineering capabilities to develop product candidates. MacroGenics is headquartered in Rockville, Maryland, the US.

MacroGenics Inc Key Recent Developments

Feb 25,2021: MacroGenics provides update on corporate progress and 2020 financial results
Feb 18,2021: MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
Feb 11,2021: MacroGenics Names Federica O’Brien to its Board of Directors
Nov 04,2020: MacroGenics provides update on corporate progress and third quarter 2020 financial results
Jul 30,2020: MacroGenics provides update on corporate progress and second quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

MacroGenics Inc - Key Facts
MacroGenics Inc - Key Employees
MacroGenics Inc - Key Employee Biographies
MacroGenics Inc - Major Products and Services
MacroGenics Inc - History
MacroGenics Inc - Company Statement
MacroGenics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
MacroGenics Inc - Business Description
Other Break-up: Revenue from Collaborative and Other Agreements
Performance
Other Break-up: Revenue from Government Agreements
Performance
MacroGenics Inc - Corporate Strategy
MacroGenics Inc - SWOT Analysis
SWOT Analysis - Overview
MacroGenics Inc - Strengths
MacroGenics Inc - Weaknesses
MacroGenics Inc - Opportunities
MacroGenics Inc - Threats
MacroGenics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MacroGenics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 25, 2021: MacroGenics provides update on corporate progress and 2020 financial results
Feb 18, 2021: MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
Feb 11, 2021: MacroGenics Names Federica O’Brien to its Board of Directors
Nov 04, 2020: MacroGenics provides update on corporate progress and third quarter 2020 financial results
Jul 30, 2020: MacroGenics provides update on corporate progress and second quarter 2020 financial results
Jun 16, 2020: MacroGenics appoints Dr. Stephen Eck As Chief Medical Officer
May 05, 2020: MacroGenics provides update on corporate progress and first quarter 2020 financial results
Mar 04, 2020: MacroGenics announces Departure of Chief Medical Officer
Feb 25, 2020: MacroGenics provides update on corporate progress and 2019 financial results
Jan 09, 2020: MacroGenics outlines corporate priorities for 2020

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

MacroGenics Inc, Key Facts
MacroGenics Inc, Key Employees
MacroGenics Inc, Key Employee Biographies
MacroGenics Inc, Major Products and Services
MacroGenics Inc, History
MacroGenics Inc, Other Locations
MacroGenics Inc, Key Competitors
MacroGenics Inc, Ratios based on current share price
MacroGenics Inc, Annual Ratios
MacroGenics Inc, Annual Ratios (Cont...1)
MacroGenics Inc, Interim Ratios
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MacroGenics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

MacroGenics Inc, Performance Chart (2016 - 2020)
MacroGenics Inc, Ratio Charts
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MacroGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021